- Dance DAB. Melioidosis: the Tip of the Iceberg? Clin Microbiol Rev 1991; 4: 52-60.
- Hirst RG, Indriana J, Cocciolone RA. An introduction to melioidosis. Innate resistance and acquired immunity to Pseudomonas pseudomallei. Aust Biol 1992; 5(4): 203-13.
- Norton R, Roberts B, Freeman M, et al. Characterisation and molecular typing of Burkholderia pseudomallei: are disease presentations of melioidosis clonally related? FEMS Immunol Med Microbiol 1998; 20: 37-44.
- Leakey AK, Ulett GC, Hirst RG. BALB/c and C57BL/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animals models for the acute and chronic forms of human melioidosis. Microbiol Pathol 1998; 24: 269-75.
- Smith CJ, Allen JC, Noor Embi M, et al. Human Melioidosis: an emerging medical problem. MIRCEN J 1987; 3: 343-66.
- Chaowagul W, Suputtamongkol Y, Dance DAB, et al. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993; 168: 1181-5.
- Tan AL, Ang BSP, Ong YY. Meliodosis: epidemiology and antibiogram of cases in Singapore. Singapore Med J 1990; 31: 335-7.
- White NJ, Dance DAB, Chaowagul W, et al. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989; 2: 697-701.
- Chaowagul W. Recent advances in treatment of severe melioidosis. International Congress on Melioidosis: State of the Art Discoveries and Trends towards the 21st Century. Program and Abstracts Booklet. 1998; PL2: 22.
- Dance DAB, Wuthiekanun V, Chaowagul W, et al. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989; 24: 295-309.
- Dance DAB, Wuthiekanun V, Chaowagul W, et al. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother 1991; 28: 321-4.
- Seymour-Murray J, Norton R, Ashhurst-Smith C. Comparative in vitro susceptibility of Burkholderia pseudomallei to cefpirome, ceftazidime and cefepime. Pathology 1997; 29: 329-30.
- Puthucheary SD, Parasakthi N. Susceptibility of 57 strains of Ps. pseudomallei to some newer B-lactams and other antibiotics. Med J Malaysia 1987; 42(4): 248-51.
- Ulett GC, Ketheesan N, Hirst RG. Macrophage-lymphocyte interactions mediate anti-Burkholderia pseudomallei activity. FEMS Immunol Med Microbiol 1998; 21: 283-6.
- Balows A. Manual of Clinical Microbiology. Chapter III, Susceptibility Tests: Diffusion Test Procedures. Washington, DC: DNLM/DLC, 1991.
- Performance Standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards. In: NCCLS M100-S6. 1995; 15 (14).
- Brody S. Bioenergetics and Growth. Chapter 13, Basal Energy and Protein Metabolism in Relation to Body Weight in Mature Animals of Different Species. New York: Hafner Press; 1974.
- Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971; 124(6): 598-606.
COMBINATION ANTIMICROBIAL THERAPY OF ACUTE BURKHOLDERIA PSEUDOMALLEI INFECTION IN A MOUSE MODEL
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.